The effects of wild-type p53 tumor suppressor activity and mutant p53 gain-of-function on cell growth

被引:184
作者
Cadwell, C [1 ]
Zambetti, GP [1 ]
机构
[1] St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA
关键词
mgain-of-function; trans activation; apoptosis and tumorigenicity;
D O I
10.1016/S0378-1119(01)00696-5
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The tumor suppressor p53 plays a central role in the protection against DNA damage and other forms of physiological stress primarily by inducing cell cycle arrest or apoptosis. Mutation of p53, which is the most frequent genetic alteration detected in human cancers, inactivates these growth regulatory functions and causes a loss of tumor suppressor activity. In some cases, mutation also confers tumor-promoting functions, such as the transcriptional activation of genes involved in cell proliferation, cell survival and angiogenesis. Consequently, cells expressing some forms of mutant p53 show enhanced tumorigenic potential with increased resistance to chemotherapy and radiation. Our current understanding of these activities is summarized in this review. By dissecting out mechanistic differences between wild-type and mutant p53 activities, it may be possible to develop therapeutics that restore tumor suppressor function to mutant p53 or that selectively inactivate mutant p53 tumor-promoting functions. (C) 2001 Published by Elsevier Science B.V.
引用
收藏
页码:15 / 30
页数:16
相关论文
共 157 条
[1]  
Abarzua P, 1996, ONCOGENE, V13, P2477
[2]  
Albor A, 1998, CANCER RES, V58, P2091
[3]   p53-dependent apoptosis is regulated by a C-terminally alternatively spliced form of murine p53 [J].
Almog, N ;
Goldfinger, N ;
Rotter, V .
ONCOGENE, 2000, 19 (30) :3395-3403
[4]  
Ashcroft M, 1999, MOL CELL BIOL, V19, P1751
[5]  
BARAK Y, 1993, EMBO J, V12, P208
[6]   The Max network gone mad [J].
Baudino, TA ;
Cleveland, JL .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (03) :691-702
[7]   Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome [J].
Bell, DW ;
Varley, JM ;
Szydlo, TE ;
Kang, DH ;
Wahrer, DCR ;
Shannon, KE ;
Lubratovich, M ;
Verselis, SJ ;
Isselbacher, KJ ;
Fraumeni, JF ;
Birch, JM ;
Li, FP ;
Garber, JE ;
Haber, DA .
SCIENCE, 1999, 286 (5449) :2528-2531
[8]   Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome [J].
Birch, JM ;
Blair, V ;
Kelsey, AM ;
Evans, DG ;
Harris, M ;
Tricker, KJ ;
Varley, JM .
ONCOGENE, 1998, 17 (09) :1061-1068
[9]   Mutant p53 gain of function: differential effects of different p53 mutants on resistance of cultured cells to chemotherapy [J].
Blandino, G ;
Levine, AJ ;
Oren, M .
ONCOGENE, 1999, 18 (02) :477-485
[10]   T cells from bax alpha transgenic mice show accelerated apoptosis in response to stimuli but do not show restored DNA damage-induced cell death in the absence of p53 [J].
Brady, HJM ;
Salomons, GS ;
Bobeldijk, RC ;
Berns, AJM .
EMBO JOURNAL, 1996, 15 (06) :1221-1230